FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 3622. Misbranding of Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules. U. S. v. Gary Drug Co., Inc., Jacob H. Raverby, and Tobias Levine. Pleas of guilty. Fine of $200 against corporation and 50 against each individual. ✖Remove constraint Titles: 3622. Misbranding of Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules. U. S. v. Gary Drug Co., Inc., Jacob H. Raverby, and Tobias Levine. Pleas of guilty. Fine of $200 against corporation and 50 against each individual. Defendants Gary Drug Co., Inc., Boston, Mass., Jacob H. Raverby, president and treasurer of the corporation, and Tobias Levine, a pharmacist employed by the corporation. ✖Remove constraint Defendants: Gary Drug Co., Inc., Boston, Mass., Jacob H. Raverby, president and treasurer of the corporation, and Tobias Levine, a pharmacist employed by the corporation. Issue Dates May 1952 ✖Remove constraint Issue Dates: May 1952 Adjudicating Courts District of Massachusetts ✖Remove constraint Adjudicating Courts: District of Massachusetts

Refine by:

  • 3622. Misbranding of Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules. U. S. v. Gary Drug Co., Inc., Jacob H. Raverby, and Tobias Levine. Pleas of guilty. Fine of $200 against corporation and 50 against each individual.1

  • Gary Drug Co., Inc., Boston, Mass., Jacob H. Raverby, president and treasurer of the corporation, and Tobias Levine, a pharmacist employed by the corporation.1